B. Riley lowered the firm’s price target on Viking Therapeutics (VKTX) to $96 from $109 and keeps a Buy rating on the shares. The firm remains ...

Citi analyst David Lebowitz initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $38 price target Viking’s VK2735 is an ...

Viking Therapeutics stock plunged early Thursday on an earnings report that included mostly incremental updates for its ...

San Diegan biotech Viking Therapeutics (Nasdaq: VKTX) has announced plans to initiate late-stage clinical trials for its ...

Stock investors may look back at 2025 as the year of the takeover - one that delivered sizeable gains. "It's going to be a big year," Calamos Investments senior portfolio manager Brandon Nelson ...

The markets have succumbed to the headline pressure around inflation and tariffs, with all three of the major stock market indices trading in the red as of mid-morning. U.S. job growth slowed in ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Fate’s Market in Remus Michigan partners with Great Start Collaborative of Mecosta, Osceola counties to make shopping into a learning experience for children.

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

The Walt Disney Company (NYSE:DIS – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders purchased 106,784 call options on the company. This is an ...